Communiqués ISR Immune System Regulation Holding AB (publ)

Actions

01/07/22	SARS-CoV-2 vaccine study approved by Bangladesh BMRC	AQ
28/06/22	ISR signs development agreements with Catalent to scale-up its spray-dried nasal vaccine, powder formulation for Phase III.	AQ
20/06/22	Delegation from Bangladesh visits ISR for study preparation	AQ
15/06/22	ISR Immune System Regulation : Holding Annual Report and Consolidated Accounts 2021 (eng) (PDF)	PU
05/05/22	Redeye Initiates Coverage of ISR Holding	AQ
23/02/22	ISR - Immune System Regulation Holding AB (publ.) 2[nd] half of 2021, including year-end report is now published on the website: www.israb.se	PU
09/09/20	ISR Immune System Regulation : Holdings AB, enters important collaboration regarding Hepatitis B with Beijing Kawin Technology Share-Holding Co., Ltd.	AQ